200 related articles for article (PubMed ID: 15861009)
41. Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats.
Iwanaga Y; Aoyama T; Kihara Y; Onozawa Y; Yoneda T; Sasayama S
J Am Coll Cardiol; 2002 Apr; 39(8):1384-91. PubMed ID: 11955860
[TBL] [Abstract][Full Text] [Related]
42. MMP induction and inhibition in myocardial infarction.
Lindsey ML
Heart Fail Rev; 2004 Jan; 9(1):7-19. PubMed ID: 14739764
[TBL] [Abstract][Full Text] [Related]
43. Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure.
Song YH; Li BS; Chen XM; Cai H
Int J Mol Med; 2008 Jan; 21(1):117-24. PubMed ID: 18097624
[TBL] [Abstract][Full Text] [Related]
44. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
Li YY; Feng YQ; Kadokami T; McTiernan CF; Draviam R; Watkins SC; Feldman AM
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12746-51. PubMed ID: 11070088
[TBL] [Abstract][Full Text] [Related]
45. Activation and release of degradative proteinases within the myocardium are the trigger for ventricular remodeling in chronic heart failure.
Sackner-Bernstein JD
Med Hypotheses; 2002 Jan; 58(1):18-23. PubMed ID: 11863394
[TBL] [Abstract][Full Text] [Related]
46. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
47. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities.
Gajarsa JJ; Kloner RA
Heart Fail Rev; 2011 Jan; 16(1):13-21. PubMed ID: 20623185
[TBL] [Abstract][Full Text] [Related]
48. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
[TBL] [Abstract][Full Text] [Related]
49. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
Vanhoutte D; Schellings M; Pinto Y; Heymans S
Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
[TBL] [Abstract][Full Text] [Related]
50. Differential regulation of extracellular matrix constituents in myocardial remodeling with and without heart failure following pressure overload.
Skrbic B; Bjørnstad JL; Marstein HS; Carlson CR; Sjaastad I; Nygård S; Bjørnstad S; Christensen G; Tønnessen T
Matrix Biol; 2013 Mar; 32(2):133-42. PubMed ID: 23220517
[TBL] [Abstract][Full Text] [Related]
51. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.
Chan W; Duffy SJ; White DA; Gao XM; Du XJ; Ellims AH; Dart AM; Taylor AJ
JACC Cardiovasc Imaging; 2012 Sep; 5(9):884-93. PubMed ID: 22974800
[TBL] [Abstract][Full Text] [Related]
52. Molecular and cellular mechanisms of myocardial failure.
Colucci WS
Am J Cardiol; 1997 Dec; 80(11A):15L-25L. PubMed ID: 9412539
[TBL] [Abstract][Full Text] [Related]
53. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.
Peterson JT; Hallak H; Johnson L; Li H; O'Brien PM; Sliskovic DR; Bocan TM; Coker ML; Etoh T; Spinale FG
Circulation; 2001 May; 103(18):2303-9. PubMed ID: 11342481
[TBL] [Abstract][Full Text] [Related]
54. Matrix metalloproteinases in cardiovascular disease.
Liu P; Sun M; Sader S
Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):25B-30B. PubMed ID: 16498509
[TBL] [Abstract][Full Text] [Related]
55. [Interactions between cardiomyocytes and extracellular matrix in the failing human heart].
Schaper J; Mollnau H; Hein S; Scholz D; Münkel B; Devaux B
Z Kardiol; 1995; 84 Suppl 4():33-8. PubMed ID: 8585271
[TBL] [Abstract][Full Text] [Related]
56. Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure.
Distefano G; Sciacca P
Ital J Pediatr; 2012 Sep; 38():41. PubMed ID: 22971785
[TBL] [Abstract][Full Text] [Related]
57. Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression.
Goldsmith EC; Bradshaw AD; Spinale FG
Am J Physiol Cell Physiol; 2013 Mar; 304(5):C393-402. PubMed ID: 23174564
[TBL] [Abstract][Full Text] [Related]
58. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation.
Nishikawa N; Yamamoto K; Sakata Y; Mano T; Yoshida J; Miwa T; Takeda H; Hori M; Masuyama T
Cardiovasc Res; 2003 Mar; 57(3):766-74. PubMed ID: 12618238
[TBL] [Abstract][Full Text] [Related]
59. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
[TBL] [Abstract][Full Text] [Related]
60. Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.
DeLeon-Pennell KY; Meschiari CA; Jung M; Lindsey ML
Prog Mol Biol Transl Sci; 2017; 147():75-100. PubMed ID: 28413032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
